Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
OPCH · against 241 other Healthcare companies of similar size
Ranked #68 of 242 · scores higher than 71% of peers
Bars: peers in each 10-point band of the valuation score34 peers with a valuation score of 60–69, including OPCH · Click a bar to see the companies
Mainly thanks to its free cash flow yield, earnings yield and EBITDA yield, which are stronger than most Healthcare peers.
| Metric | OPCH | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 238 reported | 4.2% | 2.5% | 72% | 30% | |
| EBITDA yieldHigher is better · 239 reported | 6.9% | 4.5% | 68% | 50% | |
| Free cash flow yieldHigher is better · 130 reported | 6.4% | 0.8% | 96% | 20% | |
| Book yieldHigher is better · 240 reported | 26.5% | 25.8% | 51% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 37.3B HKD (≈$4.8B) | 99 | 90 | |
| 4 | 21.1B HKD (≈$2.7B) | 98 | 67 | |
| 4 | 428.3B JPY (≈$2.9B) | 98 | 59 | |
| 66 | 4.6B USD | 70 | 61 | |
| 68 | 2.4B EUR (≈$2.6B) | 69 | 69 | |
| 68 | 9.0B USD | 69 | 57 | |
| 68 | 9.2B USD | 69 | 47 | |
| 68 | 4.8B USD | 69 | 52 | |
| 68 | 5.2B CHF (≈$5.9B) | 69 | 69 | |
| 73 | 4.0B EUR (≈$4.4B) | 68 | 49 | |
| 73 | 3.9B USD | 68 | 58 | |
| 75 | 3.1B EUR (≈$3.4B) | 67 | 42 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score